| Date Filed | Type | Description |
| 09/29/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/10/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 07/10/2023 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 06/02/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/11/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/05/2023 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 04/28/2023 |
10-K/A
| Annual Report for the period ended December 31, 2022 [amend] |
| 03/31/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 02/14/2023 |
SC 13G/A
| ARMISTICE CAPITAL, LLC reports a 10% stake in BELLICUM PHARMACEUTICALS, INC. |
| 02/14/2023 |
SC 13G/A
| Ikarian Capital, LLC reports a 5.2% stake in BELLICUM PHARMACEUTICALS, INC. |
| 12/12/2022 |
8-K
| Quarterly results |
| 12/07/2022 |
8-K
| Quarterly results |
| 11/18/2022 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 11/10/2022 |
8-K
| Quarterly results |
| 11/10/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 10/24/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 10/24/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 10/14/2022 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 08/11/2022 |
8-K
| Quarterly results |
| 08/11/2022 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 08/11/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 06/16/2022 |
8-K
| Quarterly results |
| 05/24/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 05/13/2022 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 05/12/2022 |
8-K
| Quarterly results |
| 05/12/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 04/29/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/29/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 03/24/2022 |
8-K
| Quarterly results |
| 03/24/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
| 02/15/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 02/14/2022 |
SC 13G/A
| ARMISTICE CAPITAL, LLC reports a 10% stake in Bellicum Pharmaceuticals, Inc. |
| 02/14/2022 |
SC 13G/A
| Ikarian Capital, LLC reports a 5.9% stake in BELLICUM PHARMACEUTICALS, INC. |
| 02/09/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
|